busulfan has been researched along with Cardiovascular Diseases in 2 studies
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Busulfan has been previously only available in an oral formulation due to its poor water solubility." | 2.69 | A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation. ( Apperley, J; Craddock, C; Eades, A; Goldman, J; Hassan, M; Kanfer, E; Matthews, J; Nilsson, C; Olavarria, E; Timms, A, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olavarria, E | 1 |
| Hassan, M | 1 |
| Eades, A | 1 |
| Nilsson, C | 1 |
| Timms, A | 1 |
| Matthews, J | 1 |
| Craddock, C | 1 |
| Kanfer, E | 1 |
| Apperley, J | 1 |
| Goldman, J | 1 |
| Kobayashi, I | 1 |
| Yamazaki, H | 1 |
| Didisheim, P | 1 |
1 trial available for busulfan and Cardiovascular Diseases
| Article | Year |
|---|---|
A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation.
Topics: Acute Disease; Adult; Busulfan; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Cyc | 2000 |
1 other study available for busulfan and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiopulmonary dysfunctions caused by ADP-induced platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Blood Cell Count; Blood Pressure; Bradycardia; Busulfan; Cardiovascu | 1975 |